Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access

Long Versus Short Axis Approach for Ultrasound Guided Peripheral Intravenous Access: A Randomized Control Trial

To compare a long axis approach versus short axis when placing peripheral IVs using ultrasound guidance.

Study Overview

• Status: Not yet recruiting
• Conditions: Venous Access
• Intervention / Treatment: Procedure: Intravenous access method

Detailed Description

Patients needing an USGPIV will be randomized into long or short axis orientation. Emergency Medicine residents will place the IV using an ultrasound.

• Study Type: Interventional
• Enrollment (Estimated): 98
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Ryan C Gibbons, MD; Phone Number: 6106137408; Email: ryan.gibbons@tuhs.temple.edu

Study Locations

• United States
  • Pennsylvania
    • Philadelphia, Pennsylvania, United States, 19140
      • Lewis Katz School of Medicine at Temple University
      • Contact: Ryan C Gibbons, MD; Phone Number: 610-613-7408; Email: ryan.gibbons@tuhs.temple.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 99 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Hemodynamically stable patients requiring placement of an USGPIV.

Exclusion Criteria:

• Hemodynamically unstable
• Unable to consent

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Long Axis approach; Utilize the longitudinal orientation when placing an USGPIV.	Procedure: Intravenous access method; Comparing long and short axis approach to USGPIV access.
Active Comparator: Short axis approach; Utilize the transverse orientation when placing an USGPIV.	Procedure: Intravenous access method; Comparing long and short axis approach to USGPIV access.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
First pass success	USGPIV access	1 day
Number of attempts	USGPIV access	1 day
Overall success	USGPIV access	1 day
Time to completion	USGPIV access	1 day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Complications	USGPIV access	1 day

Collaborators and Investigators

• Sponsor: Temple University
• Investigators: Principal Investigator: Ryan C Gibbons, MD, Temple University

Study record dates

Study Major Dates

• Study Start (Estimated): May 1, 2024
• Primary Completion (Estimated): December 1, 2025
• Study Completion (Estimated): December 1, 2025

Study Registration Dates

• First Submitted: January 15, 2020
• First Submitted That Met QC Criteria: January 16, 2020
• First Posted (Actual): January 21, 2020

Study Record Updates

• Last Update Posted (Actual): April 11, 2024
• Last Update Submitted That Met QC Criteria: April 9, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 26147

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No